Bovie Medical Corporation (the “Company”) (NYSE-AMEX: BVX), a manufacturer and marketer of electrosurgical products, today announced it has named J. Robert Saron as president of the Company and appointed Lawrence Waldman and Michael Geraghty to serve on the Company’s Board of Directors effective March 15, 2011.
Mr. J. Robert Saron has served as a director of the Company since 1988 to present and is currently the Chief Sales and Marketing Officer. Mr. Saron also currently serves on one industry board as past president and director of the Health Care Manufacturing Management Council and formerly served as a director on the Health Industry Distributors Association Education Foundation. Mr. Saron has over 32 years of executive marketing and distribution experience in the medical industry.
Mr. Andrew Makrides, who previously held the position of president, will remain CEO and Chairman of the Board of Directors.
Mr. Lawrence Waldman is a certified public accountant and is currently the Partner-in-Charge of the Commercial Audit Practice Development of the accounting firm Holtz Rubenstein Reminick LLP. He has significant experience in public accounting, including over thirty years as an audit partner working with a wide range of public and privately-held clients. He possesses extensive knowledge and experience in all aspects of SEC periodic reporting and will serve on Bovie’s audit committee. Mr. Waldman has served on several civic, charitable, industry and business boards throughout the Long Island area. He is also an associate Adjunct professor of accounting theory and auditing in the graduate school at the Hofstra University School of Business.Mr. Michael Geraghty has over twenty-five years of sales management experience in the medical /surgical device field. He currently serves as Executive Vice President of Global sales for Optos Inc., a manufacturer and marketer of retinal imaging devices for screening, detection and diagnosis of eye related conditions. Mr. Geraghty specializes in building independent direct sales teams in the medical device industry and has extensive domestic and international sales and marketing experience.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV